1. Introduction {#sec1}
===============

Colorectal cancer (CRC) incidence is higher in inflammatory bowel disease (IBD) patients than in the general population, and CRC accounts for an estimated 10--15% of deaths in patients with IBD \[[@B1]\]. The risk conferred by IBD may be due to chronic inflammation combined with genetic factors \[[@B1]--[@B3]\]. Patients with extensive inflammation, a younger age at diagnosis, long disease duration, comorbid primary sclerosing cholangitis (PSC), and pseudopolyposis are at the highest risk \[[@B4]--[@B14]\].

IBD patients receiving immunomodulators may or may not also be at higher risk of lymphoproliferative disorders such as lymphoma and leukemia \[[@B15]--[@B19]\]. The risk of lymphoma in IBD patients is low but appears to be higher than in the general population \[[@B6], [@B8], [@B14], [@B20]--[@B22]\]. The risk of leukemia in IBD is less clear \[[@B6], [@B8], [@B14], [@B23], [@B24]\].

Understanding the risk of development of these malignancies inherent to IBD is crucial for cancer surveillance strategies. In addition, determination of the absolute increase in risk of these malignancies from IBD pharmacotherapy is a crucial consideration for providers and patients. The aims of this study are to estimate the incidence of CRC, leukemia, and lymphoma in adult IBD patients through a systematic review and meta-analysis. Unique to this study, we attempt to evaluate the underlying risk of these cancers in IBD overall and separately Crohn\'s Disease (CD) and ulcerative colitis (UC) and exclude the effects of IBD pharmacotherapy (specifically immunomodulators and biologics), given the evidence that these medications may increase cancer risk.

2. Materials and Methods {#sec2}
========================

2.1. Literature Search {#sec2.1}
----------------------

A detailed literature search was conducted to identify all published and unpublished studies examining the incidence of CRC, leukemia, and lymphoma in adult IBD patients. We searched the PubMed, Cochrane Library, Medline, Web of Science, Scopus, EMBASE, and ProQuest Dissertations and Theses databases. Reference lists of published articles were hand searched for secondary sources and experts in the field contacted for unpublished data. Furthermore, <https://clinicaltrials.gov/>, the WHO International Clinical Trial Registry, and scientific information packets of approved IBD pharmacotherapies were scrutinized for additional information sources. No restrictions on language, country of origin, or publication date were used. [Figure 1](#fig1){ref-type="fig"} outlines the literature search and Supplementary Table  1 (in Supplementary Material available online at <http://dx.doi.org/10.1155/2016/1632439>) details the search strategy employed.

2.2. Inclusion and Exclusion Criteria {#sec2.2}
-------------------------------------

All studies that reported incidence or provided information sufficient to accurately calculate incidence for the three cancers of interest in adult IBD patients were included. Studies focusing on pediatric populations, not reporting person-years of follow-up, of duration less than one year, and not written in English and unable to be translated to English were excluded. If publications reported duplicate data on a population, only the publication with the longest follow-up period was included.

2.3. Data Collection and Quality Assessment {#sec2.3}
-------------------------------------------

Two independent reviewers (CW and KCS) examined each article for inclusion according to the eligibility criteria. Any disagreement was resolved through discussion and consensus. Thirty-six articles fulfilled the inclusion criteria. Twenty-five articles reported incidence estimates for CRC \[[@B7], [@B10], [@B11], [@B13], [@B14], [@B18], [@B19], [@B21], [@B22], [@B24]--[@B39]\], ten for leukemia \[[@B8], [@B14], [@B18], [@B19], [@B21]--[@B24], [@B33], [@B39]\], and twenty-one for lymphoma \[[@B8], [@B10], [@B14], [@B18], [@B19], [@B21], [@B22], [@B24], [@B26], [@B33], [@B34], [@B39]--[@B48]\] (some articles reported incidence estimates for multiple cancers). [Figure 1](#fig1){ref-type="fig"} outlines the search flowchart.

We retrieved demographic (where possible) and outcome data for each included article using standardized forms. Individual studies were assigned a bias risk rating using the Cochrane Collaboration\'s Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions (ACROBAT-NRSI) \[[@B49]\]. The strength of evidence for each cancer was assessed utilizing the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach \[[@B50]\].

2.4. Statistical Analysis {#sec2.4}
-------------------------

Individual study unadjusted incidence rates (per 100,000 person-years \[py\]) were calculated from the reported number of cancer cases and person-years of follow-up for each outcome separately. Standard errors and 95% confidence intervals (CIs) were estimated assuming a Poisson distribution \[[@B51]\]. In situations with zero observed cases, the value of 3.7 was used to calculate incidence rates and the confidence interval upper limit \[[@B51]\].

As our interest is in quantifying the incidence rate of CRC, leukemia, and lymphoma in IBD patients not treated with immunomodulators or biologic agents (and treatment information is often unreported), two stratification variables were created using study publication year as an estimate of when each medication class became widely used. 1995 was used as the dividing year for widespread immunomodulator use and 2000 for biologic use. Pooled incidence rates with 95% CIs were then calculated for (1) each cancer overall, (2) each cancer in CD and UC separately, (3) each cancer stratified by year of publication, and (4) each cancer stratified by country of origin (to determine if incidence varied by geographic region). A random effects model was used to account for potential between-study variations. The *I* ^2^ statistic was used to quantify the percentage of heterogeneity for all pooled estimates from between-study variation, with ≥75% indicating substantial heterogeneity \[[@B52]\]. Publication bias and the presence of other small study effects were measured through visual assessment of funnel plot symmetry and Egger\'s test \[[@B52]\]. Sensitivity analyses were undertaken to explore potential sources of heterogeneity. Metaregression was used to further test the effects of study- and subject-level covariates on cancer risk, as well as the degree of between-study heterogeneity explained by the covariates through calculation of the adjusted *R* ^2^. The adjusted *R* ^2^ measures the relative reduction in the between-study variance explained by the covariates in the model and is presented as a percentage \[[@B52]\]. Statistical analysis was performed using Stata (StataCorp, College Station, TX). *p* values ≤0.05 were considered statistically significant.

3. Results and Discussion {#sec3}
=========================

3.1. Results {#sec3.1}
------------

### 3.1.1. Colorectal Cancer {#sec3.1.1}

Reported incidence rates of CRC in IBD ranged from 41.5/100,000 py (95% CI 24.5--58.5/100,000) to 543.5/100,000 py (95% CI 316.4--770.6/100,000) ([Table 1](#tab1){ref-type="table"}). Substantial heterogeneity prevented pooling of estimates using a random effects model (heterogeneity test, chi^2^ = 174.65; *p* \< 0.001; *I* ^2^ = 86.3%). Therefore, we present unpooled incidence estimates. Separate sensitivity analyses excluding the studies with the highest individual incidence estimate \[[@B31]\] and the study with the greatest weight on the pooled estimate \[[@B7]\] did not significantly change the degree of heterogeneity present.

Reported CRC incidence rates in CD ranged from 19.5/100,000 py (95% CI 0.4--38.6/100,000) to 344.9/100,000 py (95% CI 105.9--583.9/100,000) ([Table 1](#tab1){ref-type="table"}). Using a random effects model, an estimated incidence of CRC in CD of 53.3/100,000 py (95% CI 46.3--60.3/100,000) was obtained. [Figure 2](#fig2){ref-type="fig"} displays the Forest plot for the pooled estimates. In UC, the reported incidence rates ranged from 54.5/100,000 py (95% CI 30.0--79.0/100,000) to 543.5/100,000 py (95% CI 316.4--770.6/100,000). Substantial heterogeneity was again present when pooling using a random effects model (heterogeneity test, chi^2^ = 110.7; *p* \< 0.001; *I* ^2^ = 86.4%), and thus the results in UC were not pooled.

Analyses stratified by publication year and region of origin did not reveal any significant differences in results. We also conducted metaregression analyses to evaluate the potential impact of age, gender, race, Montreal Classification, disease duration, surgical history, smoking status, comorbid primary sclerosing cholangitis, presence of extraintestinal manifestations, and concomitant treatment with immunosuppressants and/or biologics on the CRC incidence in IBD. Due to the limited sample size and incomplete reporting of demographic characteristics in many studies, these analyses were underpowered. Together, age, gender, and disease duration explained a significant proportion of the between-study variability (adjusted *R* ^2^ = 65.67%); however we could not make any further conclusions regarding the impact of these covariates on CRC incidence in IBD. Evaluation of funnel plots and Egger\'s test showed evidence of small study effects and/or publication bias for IBD overall (*p* = 0.149) and weak evidence of small study effects in CD and UC (*p* = 0.005 CD; *p* = 0.05 UC). However, the power of these tests may be compromised due to small sample sizes and significant heterogeneity between studies. Given the observational nature of the included studies and the probability of bias from small study effects, the overall quality of the CRC body of evidence per the GRADE approach is low.

### 3.1.2. Leukemia {#sec3.1.2}

Reported incidence rates of leukemia in IBD ranged from 0.0/100,000 py (95% CI 0.0--3.7/100,000) to 28.4/100,000 py (95% CI −3.7--60.5/100,000) ([Table 2](#tab2){ref-type="table"}). Using a random effects model, the pooled estimated incidence of leukemia in IBD of 1.5/100,000 py was obtained (95% CI −0.02--3.0/100,000). [Figure 3](#fig3){ref-type="fig"} illustrates the Forest plot for the pooled estimates. Moderate between-study heterogeneity was seen (heterogeneity test chi^2^ = 23.8, *p* = 0.005; *I* ^2^ = 62.1%); however this is likely influenced by the small number of available studies. In CD, the range of reported incidence rates was identical to that of IBD ([Table 2](#tab2){ref-type="table"}). In UC, reported incidence rates ranged from 8.97/100,000 py (95% CI 0.2--17.8/100,000) to 25.4/100,000 py (95% CI −9.8--60.6/100,000) ([Table 2](#tab2){ref-type="table"}). The pooled incidence estimate was 0.3/100,000 py for CD (95% CI −1.0--1.6/100,000) and 13.0/100,000 py for UC (95% CI 5.8--20.3/100,000). The *I* ^2^ statistics are 44.3% (heterogeneity test, chi^2^ = 10.8, *p* = 0.096) and 0.0% (heterogeneity test, chi^2^ = 2.65, *p* = 0.449), respectively, indicating low levels of heterogeneity; however the power of this analysis is severely limited due to the small number of included studies.

Stratification by publication year and region did not impact the incidence estimates for IBD or for CD and UC separately. Furthermore, no significant effects of any study- or subject-level covariates on incidence estimates were discovered in metaregression analyses; however the small sample size again restricted the power of these tests.

As less than 10 studies were included, the interpretation of funnel plot symmetry and Egger\'s test to assess the presence of small study effects and/or publication bias are not recommended \[[@B52]\]. The overall quality of the leukemia body of evidence, per the GRADE approach, is low due to study designs and small sample size.

### 3.1.3. Lymphoma {#sec3.1.3}

Reported incidence rates for lymphoma in IBD ranged from 0.0/100,000 py (95% CI 0.0--3.7/100,000) to 81.7/100,000 py (95% CI 21.2--142.2/100,000) ([Table 3](#tab3){ref-type="table"}). Substantial heterogeneity between studies prevented pooling of estimates (heterogeneity test, chi^2^ = 591.1; *p* \< 0.001; *I* ^2^ = 96.6%). Thus, the included studies are presented as unpooled estimates. A sensitivity analysis excluding the two studies with the lowest individual incidence estimates and highest weights on the pooled estimates was conducted, with no significant corresponding decrease in heterogeneity \[[@B14], [@B21]\].

Reported incidence rates of lymphoma in CD ranged from 0.0/100,000 py (95% CI 0.0--3.7/100,000) to 62.2/100,000 py (95% CI 16.1--108.3/100,000) ([Table 3](#tab3){ref-type="table"}). For UC, the incidence rates ranged from 0.0/100,000 py (95% CI 0.0--3.7/100,000) to 76.2/100,000 py (95% CI 15.2--137.2/100,000) ([Table 3](#tab3){ref-type="table"}). A pooled incidence rate of 0.6/100,000 py (95% CI −0.5--1.6/100,000) for CD was obtained. Substantial heterogeneity prevented pooling of estimates for UC (heterogeneity test, chi^2^ = 199.5; *p* \< 0.001; *I* ^2^ = 94.5%). A sensitivity analysis excluding the study with the largest impact on the pooled estimate in UC \[[@B47]\] decreased the heterogeneity (heterogeneity test, chi^2^ = 44.79; *p* \< 0.001; *I* ^2^ = 77.7%). However, substantial heterogeneity remained, and results for UC are presented as unpooled estimates ([Figure 4](#fig4){ref-type="fig"}).

Incidence estimates stratified by publication year and region did not differ. Metaregression analysis revealed a statistically significant effect of age on lymphoma incidence in IBD. For each mean year increase in age, the incidence of lymphoma increased by approximately 2.1/100,000 py (95% CI 0.74--3.4/100,000), explaining approximately 65.8% of the between-study heterogeneity (adjusted *R* ^2^ = 65.8%). No other covariate effects were found in metaregression analyses.

There was weak evidence of publication bias and/or small study effects in the IBD analysis (*p* = 0.213) and in the UC analysis (*p* = 0.824). The number of included studies for CD is less than 10; thus analyses of funnel plots and Egger\'s test are not recommended \[[@B52]\]. The overall quality of the lymphoma body of evidence, per the GRADE approach, is low due to the observational designs of available studies.

3.2. Discussion {#sec3.2}
---------------

This meta-analysis was performed in order to produce updated and reliable incidence rates for CRC, leukemia, and lymphoma in IBD patients and in CD and UC separately. We aimed to quantify cancer incidence associated with underlying IBD, without the effects of immunomodulator and biologic pharmacotherapy, but this was difficult without reliable reporting of treatment information in the available studies. Although we could not pool estimates of the incidence of CRC in IBD and UC specifically, a pooled incidence rate of 53.3/100,000 py (95% CI 46.3--60.3/100,000) in CD was obtained. The estimated worldwide CRC incidence rate is 19.3/100,000 py \[[@B53]\]. In more developed regions of the world, which compares to the regions of origin of the included studies, the incidence rate is higher at 59.2/100,000 py \[[@B53]\]. As such, CRC incidence in CD does not appear to be higher than that of the general population in similar areas of origin. Of note, these incidence estimates are crude (not age-adjusted) and therefore may not reflect differences in the age of the underlying populations.

For leukemia, pooled incidence rates of 1.5/100,000 py (95% CI −0.06--3.0/100,000), 0.3/100,000 py (95% CI −1.0--1.6/100,000), and 13.0/100,000 py (95% CI 5.8--20.3/100,000) were obtained for IBD, CD, and UC, respectively. The estimated worldwide leukemia incidence is 5.0/100,000 py and 11.3/100,000 py in developed regions \[[@B53]\]. Thus, the incidence of leukemia in IBD and CD is lower than that of the general population in developed regions but is slightly higher in UC. For lymphoma, substantial heterogeneity prevented the pooling of estimates for IBD and UC; however a pooled incidence rate of 0.6/100,000 py (95% CI −0.4--2.1/100,000) in CD was obtained. Estimated worldwide lymphoma incidence is 6.4/100,000 py and 17.6/100,000 py in more developed areas \[[@B53]\]. Thus, the incidence of lymphoma in CD is lower than estimated both worldwide and in developed regions.

Due to incomplete reporting of use of immunomodulators and biologics in the published literature, we could not calculate incidence rates of CRC, leukemia, and lymphoma specifically in persons not treated with these medications; however incidence estimates stratified by publication year before and after widespread use of these medications were not significantly different. This suggests that the impact of immunomodulators and biologics on the incidence of these cancers may be negligible. Metaregression did not reveal any significant subject- or study-level covariate effects in the majority of analyses, with the exception of the effect of mean age on the incidence of lymphoma in IBD. The power of these tests was limited by incomplete reporting of these variables and the small number of included studies.

The strength of the present study is the comprehensiveness of the literature search and evaluation of data for inclusion. Despite the exhaustiveness of the search, we could include only a small number of studies, limiting the power of the pooled analyses and ultimate confidence in incidence estimates. In addition, substantial heterogeneity prevented pooling of estimates in some cases. The heterogeneity of the included studies may reflect differences in follow-up time, cohort size, geographic differences in patient care, or other factors that we were unable to assess due to incomplete reporting in the published literature. Although these limitations may lead to bias in our incidence estimates, the direction of which is indeterminable, our estimates are based on the best available evidence.

4. Conclusions {#sec4}
==============

This meta-analysis presents updated estimates of the incidence of CRC, leukemia, and lymphoma in adults with IBD. Overall, the incidence of these malignancies does not appear to be higher than in the general population. Further research is needed to explore patient characteristics that may modify the risk of malignancy. Specifically, we need large population based cohort studies in IBD patients that report complete demographic and outcome data. Detailed information on immunomodulator and biologic use is limited in the published literature, and if we are to be able to truly understand the potential increased risk of malignancy associated with IBD pharmacotherapy, this information is required.

Supplementary Material {#supplementary-material-sec}
======================

###### 

Supplementary Table 1 details the search algorithms used for the systematic review. The search algorithm specific to each source are listed along with the number of results returned.

CRC:

:   Colorectal cancer

IBD:

:   Inflammatory bowel disease

PSC:

:   Primary sclerosing cholangitis

LD:

:   Lymphoproliferative disorders

CD:

:   Crohn\'s Disease

UC:

:   Ulcerative colitis

CI:

:   Confidence interval

py:

:   Person-years.
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![Flowchart depicting the identification of studies, inclusion, and exclusion assessment.](GRP2016-1632439.001){#fig1}

![Incidence of colorectal cancer (CRC) in patients with Crohn\'s Disease (CD). Each incidence estimate is presented followed by the 95% confidence intervals (CIs). Each square in the plot indicates the point estimate of the incidence. The diamond represents the summary incidence from the pooled studies. Error bars depict the 95% CIs.](GRP2016-1632439.002){#fig2}

![Incidence of leukemia in patients with inflammatory bowel disease (IBD). Each incidence estimate is presented followed by the 95% confidence intervals (CIs). Each square in the plot indicates the point estimate of the incidence. The diamond represents the summary incidence from the pooled studies. Error bars depict the 95% CIs.](GRP2016-1632439.003){#fig3}

![Incidence of lymphoma in patients with Crohn\'s Disease (CD). Each incidence estimate is presented followed by the 95% confidence intervals (CIs). Each square in the plot indicates the point estimate of the incidence. The diamond represents the summary incidence from the pooled studies. Error bars depict the 95% CIs.](GRP2016-1632439.004){#fig4}

###### 

Characteristics of included studies of CRC in IBD.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                                Journal                              Publication year   Study design   Study population        Region of origin        Number of sites   Study duration (yrs)   Person-years   Number of patients   Diagnosis   Mean age (yrs)   Female (%)   Mean disease duration (yrs)   Surgery (%)
  ------------------------------------- ------------------------------------ ------------------ -------------- ----------------------- ----------------------- ----------------- ---------------------- -------------- -------------------- ----------- ---------------- ------------ ----------------------------- -------------
  Askling  et  al.  \[[@B25]\]          Gastroenterology                     2001               Cohort         National registry       Europe (Western)        Countrywide       54                     169,332 \      19,459 \             IBD\                         48.6\                                       
                                                                                                                                                                                                        *91,833*  \    *8,810* \            *CD* \                       *53.0* \                                   
                                                                                                                                                                                                        *77,499*       *10,649*             *UC*                         *45.0*                                     

                                                                                                                                                                                                                                                                                                                    

  Bernstein  et  al.  \[[@B24]\]        Cancer                               2001               Case-control   Administrative claims   Canada                  Regionwide        14                     41,005 \       5,529 \              IBD\        39.0\            54.5\                                       
                                                                                                                                                                                                        *21,340* \     *2,857* \            *CD* \      *36.3* \         *59.0* \                                   
                                                                                                                                                                                                        *19,665*       *2,672*              *UC*        *41.7*           *50.0*                                     

                                                                                                                                                                                                                                                                                                                    

  Farrell  et  al.  \[[@B26]\]          Gut                                  2000               Cohort         Referral center         Europe (Western)        1                 9                      6,256          782                  IBD^*∗*^    44.1             52.0         10.0                           

                                                                                                                                                                                                                                                                                                                    

  Fraser  et  al.  \[[@B18]\]           Aliment Pharmacol Ther               2002               Cohort         Referral center         Europe (Western)        Countywide        35                     55,388 \       1,578 \              IBD\        35.0             53.0                                        
                                                                                                                                                                                                        *20,494* \     *584* \              *CD* \                                                                  
                                                                                                                                                                                                        *34,894*       *994*                *UC*                                                                    

                                                                                                                                                                                                                                                                                                                    

  Gillen  et  al.  \[[@B27]\]           Gut                                  1994               Cohort         Referral center         Europe (Western)        Countrywide       30                     12,324 \       611 \                IBD\                                                                     
                                                                                                                                                                                                        *2,320* \      *125* \              *CD* \                                                                  
                                                                                                                                                                                                        *10,004*       *486*                *UC*                                                                    

                                                                                                                                                                                                                                                                                                                    

  Herrinton  et  al.  \[[@B28]\]        Gastroenterology                     2012               Cohort         Administrative claims   United States           Countywide        12                     61,793 \       14,875 \             IBD\        61.8\                                                        
                                                                                                                                                                                                        *28,469* \     *5,053* \            *CD* \      *62.4* \                                                    
                                                                                                                                                                                                        *33,324*       *9,822*              *UC*        *61.1*                                                      

                                                                                                                                                                                                                                                                                                                    

  Hou  et  al. \[[@B29]\]               Inflamm Bowel Dis                    2012               Cohort         National registry       United States           Countrywide       11                     112,243        20,949               UC          61.6             5.0          5.0                            

                                                                                                                                                                                                                                                                                                                    

  Jess  et  al. \[[@B7]\]               Gastroenterology                     2012               Cohort         National registry       Europe (Western)        Countywide        29                     385,608 \      47,374 \             IBD\        40.3\            55.0\                                       
                                                                                                                                                                                                        *130,391* \    *14,463* \           *CD* \      *35.7* \         *57.0* \                                   
                                                                                                                                                                                                        *255,217*      *32,911*             *UC*        *44.9*           *53.0*                                     

                                                                                                                                                                                                                                                                                                                    

  Jess  et  al. \[[@B39]\]              Aliment Pharmacol Ther               2004               Cohort         Regional registry       Europe (Western)        Regionwide        35                     6,569          374                  CD                           58.0                                        

                                                                                                                                                                                                                                                                                                                    

  Jussila  et  al. \[[@B10]\]           Scand J Gastroenterol                2013               Cohort         National registry       Europe (Western)        Countrywide       23                     232,536 \      20,970 \             IBD\                                                                    
                                                                                                                                                                                                        *51,876* \     *4,983* \            *CD* \                                                                  
                                                                                                                                                                                                        *180,660*      *15,987*             *UC*                                                                    

                                                                                                                                                                                                                                                                                                                    

  Lakatos  et  al. \[[@B38]\]           Inflamm Bowel Dis                    2006               Cohort         Provincial registry     Europe (Eastern)        7                 11                     8,564          723                  UC          49.0             47.0         10.0                           

                                                                                                                                                                                                                                                                                                                    

  Lakatos  et  al. \[[@B30]\]           J Crohn\'s Colitis                   2011               Cohort         Provincial registry     Europe (Eastern)        7                 31                     5,758          506                  CD          31.5             50.4                                       31.0

                                                                                                                                                                                                                                                                                                                    

  Lennard-Jones  et  al. \[[@B31]\]     Gut                                  1990               Cohort         Surveillance            Europe (Western)        1                 21                     4,048          401                  UC                           42.6                                        

                                                                                                                                                                                                                                                                                                                    

  Lovasz  et  al.  \[[@B32]\]           J Gastroenterol Liver Dis            2013               Cohort         Provincial registry     Europe (Eastern)        Regionwide        34                     7,759          640                  CD          28.0             49.8         11.0                          38.4

                                                                                                                                                                                                                                                                                                                    

  Manninen  et  al.  \[[@B11]\]         J Crohn\'s Colitis                   2013               Cohort         Referral center         Europe (Western)        1                 21                     22,900 \       1,804 \              IBD\        33.0\            47.0\        13.5\                         46.0
                                                                                                                                                                                                        *7,265* \      *551* \              *CD* \      *30.0* \         *51.0* \     *13.0* \                      
                                                                                                                                                                                                        *15,635*       *1,253*              *UC*        *34.0*           *45.0*       *13.1*                        

                                                                                                                                                                                                                                                                                                                    

  Mellemkjær  et  al.  \[[@B33]\]       Cancer Causes Control                2000               Cohort         National registry       Europe (Western)        Countrywide       16                     22,875         2,645                CD                           50.0                                        

                                                                                                                                                                                                                                                                                                                    

  Mizushima  et  al.  \[[@B21]\]        Digestion                            2010               Cohort         Referral center         Asia                    1                 20                     4,248          294                  CD          39.0             30.6                                        

                                                                                                                                                                                                                                                                                                                    

  Palli  et  al.  \[[@B22]\]            Gastroenterology                     2000               Cohort         Regional registry       Europe (Western)        1                 19                     10,592 \       920 \                IBD\                                                                     
                                                                                                                                                                                                        *2,716* \      *231* \              *CD* \                                                                  
                                                                                                                                                                                                        *7,877*        *689*                *UC*                                                                    

                                                                                                                                                                                                                                                                                                                    

  Pasternak  et  al.    \[[@B34]\]      Am J Epidemiology                    2013               Cohort         National registry       Europe (Western)        Countrywide       11                     304,992        38,772               IBD^*∗*^    47.0             55.0                                       4.0

                                                                                                                                                                                                                                                                                                                    

  Selinger  et  al. \[[@B13]\]          Clin Gastroenterol Hepatol           2014               Cohort         Referral center         Australia/New Zealand   2                 15                     13,423 \       881 \                IBD\        31.5\            53.1\                                       
                                                                                                                                                                                                        *5,417* \      *377* \              *CD* \      *29.0* \         *59.1* \                                   
                                                                                                                                                                                                        *8,006*        *504*                *UC*        *34.0*           *47.1*                                     

                                                                                                                                                                                                                                                                                                                    

  van  Schaik    et  al. \[[@B35]\]     Gut                                  2012               Cohort         National registry       Europe (Western)        Countrywide       8                      4,864          835                  IBD^*∗*^    43.0             57.0         2.9                            

                                                                                                                                                                                                                                                                                                                    

  Venkataraman  et  al.    \[[@B36]\]   Australian J Gastroenterol Hepatol   2005               Cohort         Referral center         Asia                    1                 25                     4,901          532                  UC                           36.8         6.0                           8.8

                                                                                                                                                                                                                                                                                                                    

  Wandall  et  al.   \[[@B37]\]         Scand J Gastroenterol                2000               Cohort         Regional registry       Europe (Western)        Regionwide        25                     8,101          801                  UC          41.0             44.8         10.1                          15.9

                                                                                                                                                                                                                                                                                                                    

  Winther  et  al.    \[[@B19]\]        Clin Gastroenterol Hepatol           2004               Cohort         Regional registry       Europe (Western)        Regionwide        35                     22,290         1,160                UC                           53.4                                        

                                                                                                                                                                                                                                                                                                                    

  Yano  et  al.  \[[@B14]\]             J Gastroenterol Hepatol              2013               Cohort         Referral center         Asia                    1                 25                     10,552         770                  CD          25.1             31.3         13.1                           
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^*∗*^Did not report separate incidence estimates for CD and UC.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                            Journal                              Publication year   PSC (%)   Pancolitis (%)   Immunomodulator use (%)   Biologic use (%)   Observed number of CRCs   Incidence rate (per 100,000 persons)   Standard error   95% CI lower bound   95% CI upper bound   Bias rating
  --------------------------------- ------------------------------------ ------------------ --------- ---------------- ------------------------- ------------------ ------------------------- -------------------------------------- ---------------- -------------------- -------------------- -------------
  Askling et al. \[[@B25]\]         Gastroenterology                     2001                         10.3\                                                         143\                      84.4\                                  7.1\             70.6\                98.2\                Moderate
                                                                                                      *17.0* \                                                      *40* \                    *43.6* \                               *6.9* \          *30.1* \             *57.1* \             
                                                                                                      *4.8*                                                         *103*                     *132.9*                                *13.1*           *107.2*              *158.6*              

                                                                                                                                                                                                                                                                                                

  Bernstein et al. \[[@B24]\]       Cancer                               2001                                          0.0\                      0.0\               60\                       146.3\                                 18.9\            109.3\               183.3\               Moderate
                                                                                                                       *0.0* \                   *0.0* \            *24* \                    *112.5* \                              *23.0* \         *67.5* \             *157.5* \            
                                                                                                                       *0.0*                     *0.0*              *36*                      *183.1*                                *30.5*           *123.3*              *242.9*              

                                                                                                                                                                                                                                                                                                

  Farrell et al. \[[@B26]\]         Gut                                  2000                         26.0             30.0                                         3                         48.0                                   27.7             −6.3                 102.3                Moderate

                                                                                                                                                                                                                                                                                                

  Fraser et al. \[[@B18]\]          Aliment Pharmacol Ther               2002                         30.0             0.0\                      0.0\               23\                       41.5\                                  8.7\             24.5\                58.5\                Moderate
                                                                                                                       *0.0* \                   *0.0* \            *4* \                     *19.5* \                               *9.8* \          *0.4* \              *38.6* \             
                                                                                                                       *0.0*                     *0.0*              *19*                      *54.5*                                 *12.5*           *30.0*               *79.0*               

                                                                                                                                                                                                                                                                                                

  Gillen et al. \[[@B27]\]          Gut                                  1994                                                                                       37\                       300.2\                                 49.4\            203.5\               396.9\               Moderate
                                                                                                                                                                    *8* \                     *344.9* \                              *121.9* \        *105.9* \            *583.9* \            
                                                                                                                                                                    *29*                      *289.9*                                *53.8*           *184.4*              *395.4*              

                                                                                                                                                                                                                                                                                                

  Herrinton et al. \[[@B28]\]       Gastroenterology                     2012                                                                                       82\                       132.7\                                 14.7\            104.0\               161.4\               Moderate
                                                                                                                                                                    *29* \                    *101.9* \                              *18.9* \         *64.8* \             *139.0* \            
                                                                                                                                                                    *53*                      *159.0*                                *21.8*           *116.2*              *201.8*              

                                                                                                                                                                                                                                                                                                

  Hou et al. \[[@B29]\]             Inflamm Bowel Dis                    2012                                                                                       183                       163.0                                  12.0             139.4                186.6                Moderate

                                                                                                                                                                                                                                                                                                

  Jess et al. \[[@B7]\]             Gastroenterology                     2012                                                                                       338\                      87.7\                                  4.8\             78.4\                97.0\                Moderate
                                                                                                                                                                    *70* \                    *53.7* \                               *6.4* \          *41.1* \             *66.3* \             
                                                                                                                                                                    *268*                     *105.0*                                *6.4*            *92.4*               *117.6*              

                                                                                                                                                                                                                                                                                                

  Jess et al. \[[@B39]\]            Aliment Pharmacol Ther               2004                                                                                       4                         60.9                                   30.4             1.2                  120.6                Moderate

                                                                                                                                                                                                                                                                                                

  Jussila et al. \[[@B10]\]         Scand J Gastroenterol                2013                                                                                       189\                      81.3\                                  5.9\             69.7\                92.9\                Moderate
                                                                                                                                                                    *32* \                    *61.7* \                               *10.9* \         *40.3* \             *83.1* \             
                                                                                                                                                                    *157*                     *86.9*                                 *6.9*            *73.3*               *100.5*              

                                                                                                                                                                                                                                                                                                

  Lakatos et al. \[[@B38]\]         Inflamm Bowel Dis                    2006               2.9       25.8                                                          13                        151.8                                  42.1             69.3                 234.3                Moderate

                                                                                                                                                                                                                                                                                                

  Lakatos et al. \[[@B30]\]         J Crohn\'s Colitis                   2011               1.8                                                                     5                         86.8                                   38.8             10.7                 162.9                Moderate

                                                                                                                                                                                                                                                                                                

  Lennard-Jones et al. \[[@B31]\]   Gut                                  1990                                                                                       22                        543.5                                  115.9            316.4                770.6                Moderate

                                                                                                                                                                                                                                                                                                

  Lovasz et al. \[[@B32]\]          J Gastroenterol Liver Dis            2013               0.9       34.5             47.2                      7.7                6                         77.3                                   31.6             15.4                 139.2                Moderate

                                                                                                                                                                                                                                                                                                

  Manninen et al. \[[@B11]\]        J Crohn\'s Colitis                   2013               2.5\      43.2\                                                         21\                       91.7\                                  20.0\            52.5\                130.9\               Moderate
                                                                                            *1.1* \   *37.7* \                                                      *5* \                     *68.8* \                               *30.8* \         *8.5* \              *129.1* \            
                                                                                            *3.2*     *49.4*                                                        *16*                      *102.3*                                *25.6*           *52.2*               *152.4*              

                                                                                                                                                                                                                                                                                                

  Mellemkjær et al. \[[@B33]\]      Cancer Causes Control                2000                                                                                       15                        65.6                                   16.9             32.4                 98.8                 Moderate

                                                                                                                                                                                                                                                                                                

  Mizushima et al. \[[@B21]\]       Digestion                            2010                         12.4                                                          6                         141.2                                  57.6             28.2                 254.2                Moderate

                                                                                                                                                                                                                                                                                                

  Palli et al. \[[@B22]\]           Gastroenterology                     2000                                                                                       12\                       113.0\                                 32.6\            49.1\                176.9\               Moderate
                                                                                                                                                                    *2* \                     *73.6* \                               *52.0* \         *−28.4* \            *175.6* \            
                                                                                                                                                                    *10*                      *127.0*                                *40.2*           *48.3*               *205.7*              

                                                                                                                                                                                                                                                                                                

  Pasternak et al. \[[@B34]\]       Am J Epidemiology                    2013                                          0.0                       0.0                380                       124.6                                  6.4              112.1                137.1                Moderate

                                                                                                                                                                                                                                                                                                

  Selinger et al. \[[@B13]\]        Clin Gastroenterol Hepatol           2014                         38.4\                                                         29\                       216.0\                                 40.1\            137.4\               294.6\               Moderate
                                                                                                      *37.4* \                                                      *5* \                     *92.3* \                               *41.3* \         *11.4* \             *173.2* \            
                                                                                                      *39.1*                                                        *24*                      *299.8*                                *61.2*           *179.9*              *419.7*              

                                                                                                                                                                                                                                                                                                

  van Schaik et al. \[[@B35]\]      Gut                                  2012                         29.0             0.0                       0.0                9                         185.0                                  61.7             64.1                 305.9                Moderate

                                                                                                                                                                                                                                                                                                

  Venkataraman et al. \[[@B36]\]    Australian J Gastroenterol Hepatol   2005                         44.0                                                          5                         102.0                                  45.6             12.6                 191.4                Moderate

                                                                                                                                                                                                                                                                                                

  Wandall et al. \[[@B37]\]         Scand J Gastroenterol                2000                         18.0                                                          6                         74.1                                   30.3             14.8                 133.4                Moderate

                                                                                                                                                                                                                                                                                                

  Winther et al. \[[@B19]\]         Clin Gastroenterol Hepatol           2004                         54.0                                                          13                        58.3                                   16.2             26.6                 90.0                 Moderate

                                                                                                                                                                                                                                                                                                

  Yano et al. \[[@B14]\]            J Gastroenterol Hepatol              2013                         14.7                                                          9                         85.3                                   28.4             29.6                 141.0                Moderate
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Characteristics of included studies of leukemia in IBD.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                         Journal                      Publication year   Study design   Study population        Region of origin   Number of sites   Study duration (yrs)   Person-years   Number of patients   Diagnosis   Mean age (yrs)   Female (%)   Mean disease duration (yrs)   Surgery (%)
  ------------------------------ ---------------------------- ------------------ -------------- ----------------------- ------------------ ----------------- ---------------------- -------------- -------------------- ----------- ---------------- ------------ ----------------------------- -------------
  Bernstein et al. \[[@B24]\]    Cancer                       2001               Case-control   Administrative claims   Canada             Regionwide        14                     41,005  \      5,529  \             IBD \       39.0 \           54.5 \                                      
                                                                                                                                                                                    *21,340* \     *2,857* \            *CD* \      *36.3* \         *59.0* \                                   
                                                                                                                                                                                    *19,665*       *2,672*              *UC*        *41.7*           *50.0*                                     

                                                                                                                                                                                                                                                                                                

  Fraser et al. \[[@B18]\]       Aliment Pharmacol Ther       2002               Cohort         Referral center         Europe (Western)   Countrywide       35                     55,388         1,578                IBD^*∗*^    35.0             53.0                                        

                                                                                                                                                                                                                                                                                                

  Jess et al. \[[@B8]\]          Am J Gastroenterol           2013               Cohort         Regional registry       Europe (Western)   1                 32                     33,843 \       2,211 \              IBD \                        53.0 \                                      
                                                                                                                                                                                    *11,261* \     *774* \              *CD* \                       *57.0* \                                   
                                                                                                                                                                                    *22,582*       *1,437*              *UC*                         *49.0*                                     

                                                                                                                                                                                                                                                                                                

  Jess et al. \[[@B39]\]         Aliment Pharmacol Ther       2004               Cohort         Regional registry       Europe (Western)   Regionwide        35                     6,569          374                  CD                           58.0                                        

                                                                                                                                                                                                                                                                                                

  Lopez et al. \[[@B23]\]        Clin Gastroenterol Hepatol   2014               Cohort         National registry       Europe (Western)   Countrywide       3                      23,457         10,810               IBD^*∗*^    40.0             53.0                                        

                                                                                                                                                                                                                                                                                                

  Mellemkjær et al. \[[@B33]\]   Cancer Causes Control        2000               Cohort         National registry       Europe (Western)   Countrywide       16                     22,875         2,645                CD                           50.0                                        

                                                                                                                                                                                                                                                                                                

  Mizushima et al. \[[@B21]\]    Digestion                    2010               Cohort         Referral center         Asia               1                 20                     4,248          294                  CD          39.0             30.6                                        

                                                                                                                                                                                                                                                                                                

  Palli et al. \[[@B22]\]        Gastroenterology             2000               Cohort         Regional registry       Europe (Western)   1                 19                     10,592 \       920 \                IBD \                                                                    
                                                                                                                                                                                    *2,716* \      *231* \              *CD* \                                                                  
                                                                                                                                                                                    *7,877*        *689*                *UC*                                                                    

                                                                                                                                                                                                                                                                                                

  Winther et al. \[[@B19]\]      Clin Gastroenterol Hepatol   2004               Cohort         Regional registry       Europe (Western)   Regionwide        35                     22,290         1,160                UC                           53.4                                        

                                                                                                                                                                                                                                                                                                

  Yano et al. \[[@B14]\]         J Gastroenterol Hepatol      2013               Cohort         Referral center         Asia               1                 25                     10,552         770                  CD          25.1             31.3         13.1                           
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                         Journal                      Publication year   PSC (%)   Pancolitis (%)   Immunomodulator use (%)   Biologic use (%)   Observed number of leukemia cases   Incidence rate (per 100,000 persons)   Standard error   95% CI lower bound   95% CI upper bound   Bias rating
  ------------------------------ ---------------------------- ------------------ --------- ---------------- ------------------------- ------------------ ----------------------------------- -------------------------------------- ---------------- -------------------- -------------------- -------------
  Bernstein et al. \[[@B24]\]    Cancer                       2001                                          0.0 \                     0.0 \              7 \                                 17.1 \                                 6.5 \            4.4 \                29.8 \               Moderate
                                                                                                            *0.0* \                   *0.0* \            *3* \                               *14.1* \                               *8.1* \          *−1.9* \             *30.1* \             
                                                                                                            *0.0*                     *0.0*              *4*                                 *20.3*                                 *10.2*           *0.4*                *40.2*               

                                                                                                                                                                                                                                                                                               

  Fraser et al. \[[@B18]\]       Aliment Pharmacol Ther       2002                         30.0             0.0                       0.0                1                                   1.81                                   1.8              −1.7                 5.4                  Moderate

                                                                                                                                                                                                                                                                                               

  Jess et al. \[[@B8]\]          Am J Gastroenterol           2013                         26.7 \           27.2 \                                       6 \                                 17.7 \                                 7.2 \            3.5 \                31.9 \               Moderate
                                                                                           *41.0* \         *45.0* \                                     *1* \                               *8.9* \                                *8.9* \          *−8.5* \             *26.3* \             
                                                                                           *19.0*           *18.0*                                       *5*                                 *22.1*                                 *9.9*            *2.7*                *41.5*               

                                                                                                                                                                                                                                                                                               

  Jess et al. \[[@B39]\]         Aliment Pharmacol Ther       2004                                                                                       1                                   15.2                                   15.2             −14.6                45.1                 Moderate

                                                                                                                                                                                                                                                                                               

  Lopez et al. \[[@B23]\]        Clin Gastroenterol Hepatol   2014                                          0.0                       0.0                0.5                                 2.13                                   3.0              −3.8                 8.0                  Moderate

                                                                                                                                                                                                                                                                                               

  Mellemkjær et al. \[[@B33]\]   Cancer Causes Control        2000                                                                                       3                                   13.1                                   7.6              −1.7                 27.9                 Moderate

                                                                                                                                                                                                                                                                                               

  Mizushima et al. \[[@B21]\]    Digestion                    2010                         12.4                                                          0                                   0.0                                                     0.0                  3.7                  Moderate

                                                                                                                                                                                                                                                                                               

  Palli et al. \[[@B22]\]        Gastroenterology             2000                                                                                       2 \                                 19.0 \                                 13.4 \           −7.3 \               45.3 \               Moderate
                                                                                                                                                         *0* \                               *0.0* \                                 \               *0.0* \              *3.7* \              
                                                                                                                                                         *2*                                 *25.4*                                 *18.0*           *−9.8*               *60.6*               

                                                                                                                                                                                                                                                                                               

  Winther et al. \[[@B19]\]      Clin Gastroenterol Hepatol   2004                         54.0                                                          4                                   8.97                                   4.5              0.2                  17.8                 Moderate

                                                                                                                                                                                                                                                                                               

  Yano et al. \[[@B14]\]         J Gastroenterol Hepatol      2013                         14.7                                                          3                                   28.4                                   16.4             −3.7                 60.5                 Moderate
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^*∗*^Did not report separate incidence measures for CD and UC.

###### 

Characteristics of included studies of lymphoma in IBD.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                            Journal                      Publication year   Study design   Study population        Region of origin   Number of sites   Study duration (yrs)   Person-years   Number of patients   Diagnosis   Mean age (yrs)   Female (%)   Mean disease duration (yrs)   Surgery (%)
  --------------------------------- ---------------------------- ------------------ -------------- ----------------------- ------------------ ----------------- ---------------------- -------------- -------------------- ----------- ---------------- ------------ ----------------------------- -------------
  Abbas et al. \[[@B40]\]           Am J Gastroenterol           2012               Cohort         National registry       United States      Countrywide       11.0                   352,429        32,039               UC          60.0             7.0                                         

                                                                                                                                                                                                                                                                                                   

  Beaugerie et al. \[[@B41]\]       Lancet                       2009               Cohort         National registry       Europe (Western)   Countrywide       3.0                    22,706  \      10,810  \            IBD \                        53.0                                        
                                                                                                                                                                                       *10,899* \     *5,153* \            *CD* \                                                                  
                                                                                                                                                                                       *11,807*       *5,657*              *UC*                                                                    

                                                                                                                                                                                                                                                                                                   

  Bernstein et al. \[[@B24]\]       Cancer                       2001               Case-control   Administrative claims   Canada             Regionwide        14.0                   41,005  \      5,529  \             IBD \       39.0 \           54.5 \                                      
                                                                                                                                                                                       *21,340* \     *2,857* \            *CD* \      *36.3* \         *59.0* \                                   
                                                                                                                                                                                       *19,665*       *2,672*              *UC*        *41.7*           *50.0*                                     

                                                                                                                                                                                                                                                                                                   

  Chiorean et al. \[[@B42]\]        Dig Dis Sci                  2011               Case-control   Referral center         United States      1                 8.4                    30,121  \      3,585  \             IBD \                                                                    
                                                                                                                                                                                       *19,127* \     *2,277* \            *CD* \                                                                  
                                                                                                                                                                                       *10,994*       *1,308*              *UC*                                                                    

                                                                                                                                                                                                                                                                                                   

  Farrell et al. \[[@B26]\]         Gut                          2000               Cohort         Referral center         Europe (Western)   1                 9.0                    6,256          782                  IBD^*∗*^    44.1             52.0         10.0                           

                                                                                                                                                                                                                                                                                                   

  Fraser et al. \[[@B18]\]          Aliment Pharmacol Ther       2002               Cohort         Referral center         Europe (Western)   Countrywide       35.0                   55,388  \      1,578  \             IBD \       35.0             53.0                                        
                                                                                                                                                                                       *20,494* \     *584* \              *CD* \                                                                  
                                                                                                                                                                                       *34,894*       *994*                *UC*                                                                    

                                                                                                                                                                                                                                                                                                   

  Herrinton et al. \[[@B43]\]       Am J Gastroenterol           2011               Cohort         Administrative claims   United States      Regionwide        13.0                   67,867         16,023               IBD^*∗*^                     53.0                                        

                                                                                                                                                                                                                                                                                                   

  Jess et al. \[[@B8]\]             Am J Gastroenterol           2013               Cohort         Regional registry       Europe (Western)   1                 32.0                   33,843  \      2,211  \             IBD \                        53.0 \                                      
                                                                                                                                                                                       *11,261* \     *774* \              *CD* \                       *57.0* \                                   
                                                                                                                                                                                       *22,582*       *1,437*              *UC*                         *49.0*                                     

                                                                                                                                                                                                                                                                                                   

  Jess et al. \[[@B39]\]            Aliment Pharmacol Ther       2004               Cohort         Regional registry       Europe (Western)   Regionwide        35.0                   6,569          374                  CD                           58.0                                        

                                                                                                                                                                                                                                                                                                   

  Jussila et al. \[[@B10]\]         Scand J Gastroenterol        2013               Cohort         National registry       Europe (Western)   Countrywide       23.0                   232,536 \      20,970  \            IBD \                                                                    
                                                                                                                                                                                       *51,876* \     *4,983* \            *CD* \                                                                  
                                                                                                                                                                                       *180,660*      *15,987*             *UC*                                                                    

                                                                                                                                                                                                                                                                                                   

  Khan et al. \[[@B44]\]            Gastroenterology             2013               Cohort         National registry       United States      Countrywide       10.0                   199,046        36,891               UC          60.0             7.0                                         

                                                                                                                                                                                                                                                                                                   

  Lakatos et al. \[[@B45]\]         J Crohn\'s Colitis           2012               Cohort         Provincial registry     Europe (Eastern)   7                 31.0                   19,293  \      1,420  \             IBD \       32.5 \           48.8 \                                     22.8 \
                                                                                                                                                                                       *7,093* \      *506* \              *CD* \      *28.5* \         *50.0* \                                   *41.3* \
                                                                                                                                                                                       *12,830*       *914*                *UC*        *36.5*           *47.6*                                     *4.2*

                                                                                                                                                                                                                                                                                                   

  Lewis et al. \[[@B46]\]           Gastroenterology             2001               Cohort         National registry       Europe (Western)   Countrywide       9.0                    64,239  \      16,996  \            IBD \       47.3 \           54.0 \                                      
                                                                                                                                                                                       *24,221* \     *6,605* \            *CD* \      *44.3* \         *58.0* \                                   
                                                                                                                                                                                       *40,018*       *10,391*             *UC*        *50.3*           *50.0*                                     

                                                                                                                                                                                                                                                                                                   

  Loftus Jr. et al. \[[@B47]\]      Am J Gastroenterol           2000               Cohort         Regional registry       United States      2                 53.0                   6,662  \       454  \               IBD \                        24.0         14.9                          
                                                                                                                                                                                       *3,150* \      *216* \              *CD* \                                                                  
                                                                                                                                                                                       *3,512*        *238*                *UC*                                                                    

                                                                                                                                                                                                                                                                                                   

  Mellemkjær et al. \[[@B33]\]      Cancer Causes Control        2000               Cohort         National registry       Europe (Western)   Countrywide       16.0                   22,875         2,645                CD                           50.0                                        

                                                                                                                                                                                                                                                                                                   

  Mizushima et al. \[[@B21]\]       Digestion                    2010               Cohort         Referral center         Asia               1                 20.0                   4,248          294                  CD          39.0             30.6                                        

                                                                                                                                                                                                                                                                                                   

  Palli et al. \[[@B22]\]           Gastroenterology             2000               Cohort         Regional registry       Europe (Western)   1                 19.0                   10,592  \      920  \               IBD \                                                                    
                                                                                                                                                                                       *2,716* \      *231* \              *CD* \                                                                  
                                                                                                                                                                                       *7,877*        *689*                *UC*                                                                    

                                                                                                                                                                                                                                                                                                   

  Pasternak et al. \[[@B34]\]       Am J Epidemiology            2013               Cohort         National registry       Europe (Western)   Countrywide       11.0                   304,992        38,772               IBD^*∗*^    47.0             55.0                                       4.0

                                                                                                                                                                                                                                                                                                   

  Van Domselaar et al. \[[@B48]\]   J Gastroenterol Hepatol      2010               Cohort         Referral center         Europe (Western)   1                                        8,563          911                  IBD^*∗*^    53.0             28.6         4.8                            

                                                                                                                                                                                                                                                                                                   

  Winther et al. \[[@B19]\]         Clin Gastroenterol Hepatol   2004               Cohort         Regional registry       Europe (Western)   Regionwide        35.0                   22,290         1,160                UC                           53.4                                        

                                                                                                                                                                                                                                                                                                   

  Yano et al. \[[@B14]\]            J Gastroenterol Hepatol      2013               Cohort         Referral center         Asia               1                 25.0                   10,552         770                  CD          25.1             31.3         13.1                           
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                            Journal                      Publication year   PSC (%)   Pancolitis (%)   Immunomodulator use (%)   Biologic use (%)   Observed number of lymphomas   Incidence rate (per 100,000 persons)   Standard error   95% CI lower bound   95% CI upper bound   Bias rating
  --------------------------------- ---------------------------- ------------------ --------- ---------------- ------------------------- ------------------ ------------------------------ -------------------------------------- ---------------- -------------------- -------------------- -------------
  Abbas et al. \[[@B40]\]           Am J Gastroenterol           2012                                          0.0                       0.0                282                            80.0                                   4.8              70.7                 89.3                 Moderate

                                                                                                                                                                                                                                                                                             

  Beaugerie et al. \[[@B41]\]       Lancet                       2009                         29.6 \           0.0 \                     0.0 \              6 \                            26.4 \                                 10.8 \           5.3 \                47.5 \               Moderate
                                                                                              *13.0* \         *0.0* \                   *0.0* \            *3* \                          *27.5* \                               *15.9* \         *−3.6* \             *58.6* \             
                                                                                              *16.0*           *0.0*                     *0.0*              *3*                            *25.4*                                 *14.7*           *−3.3*               *54.1*               

                                                                                                                                                                                                                                                                                             

  Bernstein et al. \[[@B24]\]       Cancer                       2001                                          0.0 \                     0.0 \              16 \                           39.0 \                                 9.8 \            19.9 \               58.1 \               Moderate
                                                                                                               *0.0* \                   *0.0* \            *9* \                          *42.2* \                               *14.1* \         *14.6* \             *69.8* \             
                                                                                                               *0.0*                     *0.0*              *7*                            *35.6*                                 *13.5*           *9.2*                *62.0*               

                                                                                                                                                                                                                                                                                             

  Chiorean et al. \[[@B42]\]        Dig Dis Sci                  2011                                                                                       8 \                            26.6 \                                 9.4 \            8.2 \                45.0 \               Moderate
                                                                                                                                                            *5* \                          *26.1* \                               *11.7* \         *3.2* \              *49.0* \             
                                                                                                                                                            *3*                            *27.3*                                 *15.8*           *−3.6*               *58.2*               

                                                                                                                                                                                                                                                                                             

  Farrell et al. \[[@B26]\]         Gut                          2000                         26.0             30.0                                         4                              64.0                                   32.0             1.3                  126.7                Moderate

                                                                                                                                                                                                                                                                                             

  Fraser et al. \[[@B18]\]          Aliment Pharmacol Ther       2002                         30.0             0.0 \                     0.0 \              5 \                            9.0 \                                  4.0 \            1.1 \                16.9 \               Moderate
                                                                                                               *0.0* \                   *0.0* \            *1* \                          *4.87* \                               *4.9* \          *−4.7* \             *14.4* \             
                                                                                                               *0.0*                     *0.0*              *4*                            *11.5*                                 *5.8*            *0.2*                *22.8*               

                                                                                                                                                                                                                                                                                             

  Herrinton et al. \[[@B43]\]       Am J Gastroenterol           2011                                          0.0                       0.0                33                             48.6                                   8.5              32.0                 65.2                 Moderate

                                                                                                                                                                                                                                                                                             

  Jess et al. \[[@B8]\]             Am J Gastroenterol           2013                         26.7 \           27.2 \                                       15 \                           44.3 \                                 11.4 \           21.9 \               66.7 \               Moderate
                                                                                              *41.0* \         *45.0* \                                     *7* \                          *62.2* \                               *23.5* \         *16.1* \             *108.3* \            
                                                                                              *19.0*           *18.0*                                       *8*                            *35.4*                                 *12.5*           *10.9*               *59.9*               

                                                                                                                                                                                                                                                                                             

  Jess et al. \[[@B39]\]            Aliment Pharmacol Ther       2004                                                                                       0                              0.0                                                     0.0                  3.7                  Moderate

                                                                                                                                                                                                                                                                                             

  Jussila et al. \[[@B10]\]         Scand J Gastroenterol        2013                                                                                       72 \                           31.0 \                                 3.7 \            23.8 \               38.2 \               Moderate
                                                                                                                                                            *14* \                         *27.0* \                               *7.2* \          *12.9* \             *41.1* \             
                                                                                                                                                            *58*                           *32.1*                                 *4.2*            *23.8*               *40.4*               

                                                                                                                                                                                                                                                                                             

  Khan et al. \[[@B44]\]            Gastroenterology             2013                                          0.0                       0.0                119                            60.0                                   5.5              49.2                 70.8                 Moderate

                                                                                                                                                                                                                                                                                             

  Lakatos et al. \[[@B45]\]         J Crohn\'s Colitis           2012               2.3 \     30.2 \           0.0 \                     0.0 \              3 \                            15.5 \                                 8.9 \            −2.0 \               33.0 \               Moderate
                                                                                    *1.8* \   *35.9* \         *0.0* \                   *0.0* \            *1* \                          *14.1* \                               *14.1* \         *−13.5* \            *41.7* \             
                                                                                    *2.7*     *24.4*           *0.0*                     *0.0*              *2*                            *15.6*                                 *11.0*           *−6.0*               *37.2*               

                                                                                                                                                                                                                                                                                             

  Lewis et al. \[[@B46]\]           Gastroenterology             2001                                          9.5 \                                        18 \                           28.0 \                                 6.6 \            15.1 \               40.9 \               Moderate
                                                                                                               *13.0* \                                     *7* \                          *28.9* \                               *10.9* \         *7.5* \              *50.3* \             
                                                                                                               *6.0*                                        *11*                           *27.5*                                 *8.3*            *11.2*               *43.8*               

                                                                                                                                                                                                                                                                                             

  Loftus Jr. et al. \[[@B47]\]      Am J Gastroenterol           2000                                                                                       1 \                            15.0 \                                 15.0 \           −14.4 \              44.4 \               Moderate
                                                                                                                                                            *1* \                          *32.0* \                               *32.0* \         *−30.7* \            *94.7* \             
                                                                                                                                                            *0*                            *0.0*                                                   *0.0*                *3.7*                

                                                                                                                                                                                                                                                                                             

  Mellemkjær et al. \[[@B33]\]      Cancer Causes Control        2000                                                                                       4                              17.5                                   8.8              0.4                  34.7                 Moderate

                                                                                                                                                                                                                                                                                             

  Mizushima et al. \[[@B21]\]       Digestion                    2010                         12.4                                                          0                              0.0                                                     0.0                  3.7                  Moderate

                                                                                                                                                                                                                                                                                             

  Palli et al. \[[@B22]\]           Gastroenterology             2000                                                                                       7 \                            66.0 \                                 24.9 \           17.1 \               114.9 \              Moderate
                                                                                                                                                            *1* \                          *36.8* \                               *36.8* \         *−35.3* \            *108.9* \            
                                                                                                                                                            *6*                            *76.2*                                 *31.1*           *15.2*               *137.2*              

                                                                                                                                                                                                                                                                                             

  Pasternak et al. \[[@B34]\]       Am J Epidemiology            2013                                          0.0                       0.0                46                             15.1                                   2.2              10.7                 19.5                 Moderate

                                                                                                                                                                                                                                                                                             

  Van Domselaar et al. \[[@B48]\]   J Gastroenterol Hepatol      2010                                                                                       7                              81.7                                   30.9             21.2                 142.2                Moderate

                                                                                                                                                                                                                                                                                             

  Winther et al. \[[@B19]\]         Clin Gastroenterol Hepatol   2004                         54.0                                                          2                              17.9                                   12.7             −6.9                 42.8                 Moderate

                                                                                                                                                                                                                                                                                             

  Yano et al. \[[@B14]\]            J Gastroenterol Hepatol      2013                         14.7                                                          0                              0.0                                                     0.0                  3.7                  Moderate
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^*∗*^Did not report separate incidence estimates for CD and UC.

[^1]: Academic Editor: Bjørn Moum
